WPI 62.5 (Bosentan Monohydrate 62.5 mg)
Pill with imprint WPI 62.5 is Orange, Round and has been identified as Bosentan Monohydrate 62.5 mg. It is supplied by Actavis Pharma, Inc..
Bosentan is used in the treatment of pulmonary hypertension and belongs to the drug class agents for pulmonary hypertension. Not for use in pregnancy. Bosentan 62.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 62.5
Bosentan Monohydrate
- Imprint
- WPI 62.5
- Strength
- 62.5 mg
- Color
- Orange
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Agents for pulmonary hypertension
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- Manufacturer
- Watson Pharma Private Limited
- National Drug Code (NDC)
- 00591-2511
More about bosentan
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 6 Reviews
- Drug class: agents for pulmonary hypertension
Consumer resources
- Patient Information
- Bosentan (Advanced Reading)
- Bosentan Tablets
- Bosentan Tablets for Oral Suspension
- Other brands
- Tracleer
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.